Odyssean »

Corcept Therapeutics Incorporated shares owned by Odyssean

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 14k 86.95

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
First Trust Advisors
Tang Capital Management
Caption Management
UBS Group
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Corcept Therapeutics Incorporated